Knobbemedical.com, a no-cost cooperative portal that provides startup medical device companies access to comprehensive legal and supplementary resources useful for new ventures or product launches, has been commended by The Recorder as an important innovation in delivering legal services to clientele.
In the first Federal Circuit case involving the Biologics Price Competition and Innovation Act (“BPCIA” or “Biosimilars Act”), the Court of Appeals for the Federal Circuit affirmed Judge Maxine E. Chesney’s (N.D. Cal.) dismissal of Sandoz’s declaratory judgment action relating to its biosimilar version of Enbrel®. See Sandoz Inc. v. Amgen Inc., 2014-1603 (Fed. Cir. Dec. 5, 2014).
Knobbe Martens Olson & Bear LLP partner Salima Merani, Ph.D. has been featured in the Minority Corporate Counsel Association's (MCCA) November/December issue of Diversity & the Bar’s list of 2014 “Rainmakers”. The annual list profiles diverse lawyers who are leaders in their field and have an established record of developing business.
In a recent lawsuit between a biosimilar applicant and a patent owner, Judge Paul A. Crotty (S.D.N.Y.) relied onSandoz Inc. v. Amgen Inc., 3:13-cv-02904-MMC (N.D. Cal. Nov. 12, 2013) to deny declaratory relief for the biosimilar applicant, despite the applicant’s substantial investment and pending FDA application.
Knobbe Martens Olson & Bear LLP litigation partner Joseph Re was profiled in Law360 today in recognition of his selection in the publication's exclusive "MVP of the Year" awards. Attorneys selected for this honor include those with successes in high-stakes litigation, record-breaking deals, and complex global matters. Joe's accomplishments in 2014 have been remarkable, and include an October victory for longstanding client Masimo in obtaining a verdict of more than $466 million against two Philips defendants.
Knobbe Martens Olson & Bear LLP is pleased to announce that longstanding client Applied Medical Resources Corp. has resolved all of its patent litigation with Tyco Healthcare/Covidien, including a jury trial scheduled for March, 2015. The parties and their predecessors have had ongoing patent litigation over various laparoscopic-surgery related products since the mid-1990s, and Knobbe Martens has been handling those cases for Applied Medical since 2004.
A biofiltration device aimed to treat the Ebola virus, for which Knobbe Martens Olson & Bear LLP attorneys obtained key patents, was selected as one of Time’s “25 Best Inventions of 2014.” The magazine’s annual list highlights new technology that makes the world “better” and “smarter.” Other inventions chosen for the prestigious list include new technology enabling wireless electricity, Microsoft’s Surface Pro 3 laptop, bananas engineered to prevent blindness in Africa, and BMW’s first electric car.
The Federal Circuit affirmed the summary judgment of no infringement to various mobile device makers against a non-practicing entity claiming that its patent covered technology used in all Android devices. Knobbe Martens represented HTC in this win, both in the district court and Federal Circuit. Amy Chun of Knobbe, along with co-counsel for the other defendants, won the case long before trial and without giving into the exorbitant damages demand.
Joseph Re, a litigation partner at Knobbe Martens Olson & Bear LLP, has been named an “MVP of the Year” by Law360. Attorneys selected for this honor include those with successes in high-stakes litigation, record-breaking deals, and complex global matters.
We all know Brownies as the cutest little cookie sales girls around. But don’t be surprised if one day a group of second graders from Orange County trade in their pig tails and sashes for business suits and a career in patent litigation.